Tridia van der Laan
- In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosisBy Mathieu S. Bolhuis, Tridia van der Laan, Jos G.W. Kosterink, Tjip S. van der Werf, Dick van Soolingen and Jan-Willem C. AlffenaarArticle | Published in 2014 in European Respiratory JournalMathieu S. Bolhuis1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsTridia van der Laan2National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsJos G.W. Kosterink1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands3University of Groningen, Dept of Pharmacy, Section of Pharmacotherapy and Pharmaceutical Care, Groningen, The NetherlandsTjip S. van der Werf4University of Groningen, University Medical Center Groningen, Dept of Internal Medicine and Pulmonary Disease and Tuberculosis, Groningen, The NetherlandsDick van Soolingen2National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands5Radboud University Nijmegen Medical Center, Depts of Clinical Infectious Diseases, Pulmonary Diseases and Medical Microbiology, Nijmegen, The NetherlandsJan-Willem C. Alffenaar1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
- In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosisBy Mathieu S. Bolhuis, Tridia van der Laan, Jos G.W. Kosterink, Tjip S. van der Werf, Dick van Soolingen and Jan-Willem C. AlffenaarMathieu S. Bolhuis1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsTridia van der Laan2National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsJos G.W. Kosterink1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands3University of Groningen, Dept of Pharmacy, Section of Pharmacotherapy and Pharmaceutical Care, Groningen, The NetherlandsTjip S. van der Werf4University of Groningen, University Medical Center Groningen, Dept of Internal Medicine and Pulmonary Disease and Tuberculosis, Groningen, The NetherlandsDick van Soolingen2National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands5Radboud University Nijmegen Medical Center, Depts of Clinical Infectious Diseases, Pulmonary Diseases and Medical Microbiology, Nijmegen, The NetherlandsJan-Willem C. Alffenaar1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
- Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosisBy Sander P. van Rijn, Richard van Altena, Onno W. Akkerman, Dick van Soolingen, Tridia van der Laan, Wiel C.M. de Lange, Jos G.W. Kosterink, Tjip S. van der Werf and Jan-Willem C. AlffenaarArticle | Published in 2016 in European Respiratory JournalSander P. van Rijn1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy, Groningen, The Netherlands7Both authors contributed equallyRichard van Altena2University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands7Both authors contributed equallyOnno W. Akkerman2University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The NetherlandsDick van Soolingen3Radboud University Nijmegen Medical Center, Depts of Pulmonary Diseases and Medical Microbiology, Nijmegen, The Netherlands4National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsTridia van der Laan4National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsWiel C.M. de Lange2University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The NetherlandsJos G.W. Kosterink1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy, Groningen, The Netherlands5University of Groningen, University Medical Center Groningen, Section Pharmacotherapy and Pharmaceutical Care, Dept of Pharmacy, Groningen, The NetherlandsTjip S. van der Werf6University of Groningen, University Medical Center Groningen, Depts of Internal Medicine and Pulmonary Diseases and Tuberculosis, Groningen, The NetherlandsJan-Willem C. Alffenaar1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy, Groningen, The Netherlands
- Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosisBy Sander P. van Rijn, Richard van Altena, Onno W. Akkerman, Dick van Soolingen, Tridia van der Laan, Wiel C.M. de Lange, Jos G.W. Kosterink, Tjip S. van der Werf and Jan-Willem C. AlffenaarSander P. van Rijn1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy, Groningen, The Netherlands7Both authors contributed equallyRichard van Altena2University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands7Both authors contributed equallyOnno W. Akkerman2University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The NetherlandsDick van Soolingen3Radboud University Nijmegen Medical Center, Depts of Pulmonary Diseases and Medical Microbiology, Nijmegen, The Netherlands4National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsTridia van der Laan4National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The NetherlandsWiel C.M. de Lange2University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The NetherlandsJos G.W. Kosterink1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy, Groningen, The Netherlands5University of Groningen, University Medical Center Groningen, Section Pharmacotherapy and Pharmaceutical Care, Dept of Pharmacy, Groningen, The NetherlandsTjip S. van der Werf6University of Groningen, University Medical Center Groningen, Depts of Internal Medicine and Pulmonary Diseases and Tuberculosis, Groningen, The NetherlandsJan-Willem C. Alffenaar1University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy, Groningen, The Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
